(14:12 GMT) Enliven Therapeutics Price Target Raised to $80.00/Share From $60.00 by Stifel
Dow Jones Newswires
Enliven Therapeutics Is Maintained at Buy by Stifel
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:ELVN
- Language
- English